A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL.
The file type is
AbstractCell-mediated immunity (CMI), which includes T-cells (both T helper and cytotoxic), is critical for effective antiviral defenses against coronavirus disease-2019 (COVID-19). To better understand the immunological characteristics of CD markers on T-cells in post-COVID-19 patients, we investigated the expression of differential CD markers in the patient groups in this study.Flow cytometry was used to quantify total lymphocyte count and assess the levels of expression of CD markers in thedoi:10.1101/2022.07.02.22276875 fatcat:laqmjwoec5gz3mk6evmy6geim4